John Higgins

(Mr. John Higgins)

Currently holds positions in Ligand Pharmaceuticals Inc and Bio-Techne Corp

Positions

Position Company Period
Chief Executive Officer, Director Ligand Pharmaceuticals Inc Jan. 27, 2015 -
Independent Director Bio-Techne Corp May 19, 2009 -
President, Chief Executive Officer, Director Ligand Pharmaceuticals Inc March 22, 2007 - Jan. 27, 2015
Independent Director BioCryst Pharmaceuticals Inc May 1, 2004 - May 31, 2013
John Higgins's trades of OmniAb Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-21 2025-03-21
US OmniAb Inc (OABI)
B Purchase
4,000 +0.1%
2.28
USD 9,120 		4,000 +0.1% 2.28 USD 9,120
2025-03-20 2025-03-20
US OmniAb Inc (OABI)
B Purchase
125,750 +4.8%
2.35
USD 295,513 		125,750 +4.8% 2.35 USD 295,513
2024-05-16 2024-05-14
S Sale
4,000 -9.9%
83.84
USD 335,377 		4,000 -9.9% 83.84 USD 335,377
2023-05-25 2023-05-23
US OmniAb Inc (OABI)
S Sale
9,000 -0.4%
4.05
USD 36,450 		9,000 -0.4% 4.05 USD 36,450
2023-05-23 2023-05-19
US OmniAb Inc (OABI)
S Sale
1,000 -0.0%
4.05
USD 4,050 		1,000 -0.0% 4.05 USD 4,050
2023-05-19 2023-05-18
US OmniAb Inc (OABI)
S Sale
50,000 -2.0%
3.89
USD 194,500 		50,000 -2.0% 3.89 USD 194,500
2022-12-20 2022-12-16
PS Planned sale
10,000 -2.3%
61.87
USD 618,657 		10,000 -2.3% 61.87 USD 618,657
2022-11-21 2022-11-17
PS Planned sale
10,000 -2.3%
78.32
USD 783,173 		10,000 -2.3% 78.32 USD 783,173
2022-09-16 2022-09-16
S Sale
3,000 -0.8%
89.35
USD 268,050 		3,000 -0.8% 89.35 USD 268,050
2022-09-16 2022-09-15
S Sale
2,000 -0.5%
90.00
USD 180,000 		2,000 -0.5% 90.00 USD 180,000
2022-08-12 2022-08-11
S Sale
8 -0.1%
380.71
USD 3,046 		8 -0.1% 380.71 USD 3,046
2022-08-12 2022-08-11
S Sale
504 -8.4%
385.47
USD 194,277 		504 -8.4% 385.47 USD 194,277
2022-08-12 2022-08-10
S Sale
992 -14.2%
380.15
USD 377,112 		992 -14.2% 380.15 USD 377,112
2022-08-12 2022-08-10
S Sale
100 -1.4%
374.90
USD 37,490 		100 -1.4% 374.90 USD 37,490
2022-08-12 2022-08-10
S Sale
900 -11.2%
373.99
USD 336,593 		900 -11.2% 373.99 USD 336,593
2022-06-09 2022-06-08
S Sale
600 -11.5%
366.09
USD 219,654 		600 -11.5% 366.09 USD 219,654
2022-06-09 2022-06-07
S Sale
1,000 -17.8%
364.31
USD 364,310 		1,000 -17.8% 364.31 USD 364,310
2021-11-12 2021-11-12
S Sale
3,000 -0.9%
160.50
USD 481,500 		3,000 -0.9% 160.50 USD 481,500
2021-02-09 2021-02-05
S Sale
54,666 -16.0%
203.40
USD 11,119,239 		54,666 -16.0% 203.40 USD 11,119,239
2021-01-27 2021-01-27
PS Planned sale
40,000 -14.1%
182.00
USD 7,280,000 		40,000 -14.1% 182.00 USD 7,280,000
2021-01-27 2021-01-25
PS Planned sale
50,000 -17.5%
159.00
USD 7,950,000 		50,000 -17.5% 159.00 USD 7,950,000
2020-11-10 2020-11-06
S Sale
3,100 -41.3%
301.06
USD 933,301 		3,100 -41.3% 301.06 USD 933,301
2020-11-10 2020-11-06
S Sale
450 -5.7%
299.84
USD 134,928 		450 -5.7% 299.84 USD 134,928
2020-11-10 2020-11-06
S Sale
1,450 -15.4%
298.98
USD 433,516 		1,450 -15.4% 298.98 USD 433,516
2020-02-14 2020-02-12
S Sale
5,000 -55.4%
205.23
USD 1,026,133 		5,000 -55.4% 205.23 USD 1,026,133
2019-07-31 2019-07-31
B Purchase
1,850 +1.3%
95.45
USD 176,583 		1,850 +1.3% 95.45 USD 176,583
2019-06-06 2019-06-04
S Sale
5,000 -58.6%
203.67
USD 1,018,346 		5,000 -58.6% 203.67 USD 1,018,346
2019-05-31 2019-05-31
B Purchase
1,000 +0.7%
108.20
USD 108,202 		1,000 +0.7% 108.20 USD 108,202
2019-05-14 2019-05-14
B Purchase
2,500 +1.8%
113.50
USD 283,750 		2,500 +1.8% 113.50 USD 283,750
2019-03-15 2019-03-13
B Purchase
2,500 +1.8%
114.29
USD 285,725 		2,500 +1.8% 114.29 USD 285,725
// ... existing code ... // ... rest of the file ...